Market Cap 70.53M
Revenue (ttm) 0.00
Net Income (ttm) -24.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,188,900
Avg Vol 1,760,886
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 96%
Beta -1.48
Analysts Buy
Price Target $2.00

Latest News on SAVA

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 4 weeks ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data


Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 3 months ago

Cassava Sciences Provides a Business Update